WallStreetZenWallStreetZen

NASDAQ: RYTM
Rhythm Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for RYTM

Based on 4 analysts offering 12 month price targets for Rhythm Pharmaceuticals Inc.
Min Forecast
$50.00+31.06%
Avg Forecast
$52.25+36.96%
Max Forecast
$55.00+44.17%

Should I buy or sell RYTM stock?

Based on 4 analysts offering ratings for Rhythm Pharmaceuticals Inc.
Strong Buy
Strong Buy
3 analysts 75%
Buy
1 analysts 25%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their RYTM stock forecasts and price targets.

RYTM stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-18
lockedlocked$00.00+00.00%2024-04-10
lockedlocked$00.00+00.00%2024-01-26
lockedlocked$00.00+00.00%2023-12-19Find Out Why

1 of 1

Forecast return on equity

Is RYTM forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.16%

Forecast return on assets

Is RYTM forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

RYTM revenue forecast

What is RYTM's revenue in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$133.2M+72.03%
Avg 2 year Forecast
$197.4M+155.01%
Avg 3 year Forecast
$363.2M+369.06%
RYTM's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

RYTM revenue growth forecast

How is RYTM forecast to perform vs Biotechnology companies and vs the US market?
Company
64.76%
Industry
37.04%
Market
9.92%
RYTM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
RYTM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

RYTM vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
RYTM$38.15$52.25+36.96%Strong Buy
CORT$22.21$39.33+77.10%Strong Buy
APGE$45.86$69.67+51.91%Strong Buy
VCEL$45.45$53.50+17.71%Strong Buy
CGON$36.20$61.75+70.58%Strong Buy
View Top Biotech Stocks

Rhythm Pharmaceuticals Stock Forecast FAQ

Is Rhythm Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: RYTM) stock is to Strong Buy RYTM stock.

Out of 4 analysts, 3 (75%) are recommending RYTM as a Strong Buy, 1 (25%) are recommending RYTM as a Buy, 0 (0%) are recommending RYTM as a Hold, 0 (0%) are recommending RYTM as a Sell, and 0 (0%) are recommending RYTM as a Strong Sell.

If you're new to stock investing, here's how to buy Rhythm Pharmaceuticals stock.

What is RYTM's revenue growth forecast for 2024-2026?

(NASDAQ: RYTM) Rhythm Pharmaceuticals's forecast annual revenue growth rate of 64.76% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.04%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.92%.

Rhythm Pharmaceuticals's revenue in 2024 is $77,428,000.On average, 7 Wall Street analysts forecast RYTM's revenue for 2024 to be $8,010,834,215, with the lowest RYTM revenue forecast at $6,953,083,189, and the highest RYTM revenue forecast at $8,539,950,290. On average, 7 Wall Street analysts forecast RYTM's revenue for 2025 to be $11,874,620,457, with the lowest RYTM revenue forecast at $9,906,282,196, and the highest RYTM revenue forecast at $13,531,611,375.

In 2026, RYTM is forecast to generate $21,842,245,958 in revenue, with the lowest revenue forecast at $13,333,147,742 and the highest revenue forecast at $28,929,983,715.

What is RYTM's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: RYTM) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is RYTM's Price Target?

According to 4 Wall Street analysts that have issued a 1 year RYTM price target, the average RYTM price target is $52.25, with the highest RYTM stock price forecast at $55.00 and the lowest RYTM stock price forecast at $50.00.

On average, Wall Street analysts predict that Rhythm Pharmaceuticals's share price could reach $52.25 by Apr 18, 2025. The average Rhythm Pharmaceuticals stock price prediction forecasts a potential upside of 36.96% from the current RYTM share price of $38.15.

What is RYTM's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: RYTM) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.